Marienhospital Herne
Herne 44627
5 studies enrolling now · 12 studies all time
What they study most
Brain Tumor, Primary, Desmoplastic Small Round Cell Tumor, Gastroesophageal Reflux, Heart Failure, Metastatic Castration-resistant Prostate Cancer, Metastatic Urothelial Cancer, Muscle-invasive Urothelial Carcinoma, Non-Muscle Invasive Bladder Neoplasms, Receptors, Fibroblast Growth Factor, Solid Tumor, Adult, Urinary Bladder Neoplasms, Urothelial Cancer
Studies at this site
- A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer — Recruiting now
- Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy — Recruiting now
- A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer — Recruiting now
- A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer — Recruiting now
- Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC) — Running, not enrolling
- Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer — Running, not enrolling
- RETHINK REFLUX Registry — Running, not enrolling
- A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder — Completed
- Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors — Stopped early
- Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry — Completed
- A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations — Completed